Annual Accounts Payable
$9.44 M
+$4.64 M+96.79%
December 31, 2023
Summary
- As of February 7, 2025, STRO annual accounts payable is $9.44 million, with the most recent change of +$4.64 million (+96.79%) on December 31, 2023.
- During the last 3 years, STRO annual accounts payable has risen by +$3.90 million (+70.27%).
- STRO annual accounts payable is now at all-time high.
Performance
STRO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$6.22 M
+$130.00 K+2.14%
September 30, 2024
Summary
- As of February 7, 2025, STRO quarterly accounts payable is $6.22 million, with the most recent change of +$130.00 thousand (+2.14%) on September 30, 2024.
- Over the past year, STRO quarterly accounts payable has dropped by -$3.22 million (-34.15%).
- STRO quarterly accounts payable is now -50.54% below its all-time high of $12.57 million, reached on June 30, 2022.
Performance
STRO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
STRO Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +96.8% | -34.1% |
3 y3 years | +70.3% | -34.1% |
5 y5 years | +208.4% | -34.1% |
STRO Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +96.8% | -50.5% | +61.2% |
5 y | 5-year | at high | +96.8% | -50.5% | +61.2% |
alltime | all time | at high | +225.3% | -50.5% | +131.3% |
Sutro Biopharma Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $6.22 M(+2.1%) |
Jun 2024 | - | $6.09 M(-19.0%) |
Mar 2024 | - | $7.51 M(-20.4%) |
Dec 2023 | $9.44 M(+96.8%) | $9.44 M(+70.9%) |
Sep 2023 | - | $5.53 M(+43.3%) |
Jun 2023 | - | $3.86 M(-23.8%) |
Mar 2023 | - | $5.06 M(+5.4%) |
Dec 2022 | $4.80 M(-20.2%) | $4.80 M(-61.4%) |
Sep 2022 | - | $12.44 M(-1.0%) |
Jun 2022 | - | $12.57 M(+17.4%) |
Mar 2022 | - | $10.71 M(+78.1%) |
Dec 2021 | $6.01 M | $6.01 M(-46.2%) |
Sep 2021 | - | $11.17 M(+46.2%) |
Jun 2021 | - | $7.64 M(+29.7%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $5.89 M(+6.3%) |
Dec 2020 | $5.54 M(-0.7%) | $5.54 M(+13.6%) |
Sep 2020 | - | $4.88 M(-0.4%) |
Jun 2020 | - | $4.90 M(-16.1%) |
Mar 2020 | - | $5.84 M(+4.6%) |
Dec 2019 | $5.58 M(+82.4%) | $5.58 M(+22.8%) |
Sep 2019 | - | $4.55 M(+0.7%) |
Jun 2019 | - | $4.52 M(+33.0%) |
Mar 2019 | - | $3.40 M(+10.9%) |
Dec 2018 | $3.06 M(+5.5%) | $3.06 M(-33.4%) |
Sep 2018 | - | $4.59 M(+70.9%) |
Jun 2018 | - | $2.69 M(-7.4%) |
Dec 2017 | $2.90 M(-14.5%) | $2.90 M |
Dec 2016 | $3.39 M | - |
FAQ
- What is Sutro Biopharma annual accounts payable?
- What is the all time high annual accounts payable for Sutro Biopharma?
- What is Sutro Biopharma annual accounts payable year-on-year change?
- What is Sutro Biopharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Sutro Biopharma?
- What is Sutro Biopharma quarterly accounts payable year-on-year change?
What is Sutro Biopharma annual accounts payable?
The current annual accounts payable of STRO is $9.44 M
What is the all time high annual accounts payable for Sutro Biopharma?
Sutro Biopharma all-time high annual accounts payable is $9.44 M
What is Sutro Biopharma annual accounts payable year-on-year change?
Over the past year, STRO annual accounts payable has changed by +$4.64 M (+96.79%)
What is Sutro Biopharma quarterly accounts payable?
The current quarterly accounts payable of STRO is $6.22 M
What is the all time high quarterly accounts payable for Sutro Biopharma?
Sutro Biopharma all-time high quarterly accounts payable is $12.57 M
What is Sutro Biopharma quarterly accounts payable year-on-year change?
Over the past year, STRO quarterly accounts payable has changed by -$3.22 M (-34.15%)